AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36191485 — intervention group
Group type: EXPERIMENTAL
Intervention: EGCG/EC intervention
Number of subjects: 65
Study 36191485 — intervention group
Group type: EXPERIMENTAL
Intervention: EGCG/EC supplementation
Number of subjects: 65
Study 36191485 — intervention group
Group type: EXPERIMENTAL
Intervention: EGCG supplementation
Number of subjects: 65
Study 36191485 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 65
Study 34274136 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabazitaxel (25 mg/m2 plus prednisone and granulocyte colony-stimulating factor)
Number of subjects: 255
Study 34274136 — intervention group
Group type: COMPARATOR
Intervention: Abiraterone/enzalutamide
Number of subjects: 255
Study 34013650 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythritol powder air polishing and ultrasonic instrumentation (EPAP+UI)
Number of subjects: 13
Study 34013650 — intervention group
Group type: COMPARATOR
Intervention: Ultrasonic debridement and polishing (UD+P)
Number of subjects: 13
Study 33449432 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent training intervention supporting home oral hygiene and dental visits
Number of subjects: 118
Study 33449432 — intervention group
Group type: EXPERIMENTAL
Intervention: Hispanic caregivers
Number of subjects: 118
Study 33449432 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregivers living alone with children
Number of subjects: 118
Study 33449432 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariable analysis
Number of subjects: 118
Study 33449432 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall findings
Number of subjects: 118
Study 35605339 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated rehabilitation pathway
Number of subjects: 44
Study 35605339 — intervention group
Group type: COMPARATOR
Intervention: Control rehabilitation pathway
Number of subjects: 44
Study 34779349 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (1 year of 150 min weekly combined strength and endurance exercise)
Number of subjects: 137
Study 34779349 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group
Number of subjects: 137
Study 34779349 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 137
Study 34715757 — intervention group
Group type: EXPERIMENTAL
Intervention: FIR (Far Infrared Radiation)
Number of subjects: 20
Study 34715757 — intervention group
Group type: COMPARATOR
Intervention: Control (no FIR)
Number of subjects: 20
Study 33517741 — intervention group
Group type: EXPERIMENTAL
Intervention: US-guided injection
Number of subjects: 90
Study 33517741 — intervention group
Group type: COMPARATOR
Intervention: Blind injection
Number of subjects: 90
Study 33517741 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 90
Study 32023617 — intervention group
Group type: EXPERIMENTAL
Intervention: Tongue-strengthening exercises 3 times per week (EX3)
Number of subjects: 20
Study 32023617 — intervention group
Group type: EXPERIMENTAL
Intervention: Tongue-strengthening exercises 5 times per week (EX5)
Number of subjects: 20
Study 32023617 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 20
Study 35551484 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 100
Study 35551484 — intervention group
Group type: COMPARATOR
Intervention: Non-surgical treatment
Number of subjects: 100
Study 33191260 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (ASA) 650 mg
Number of subjects: 0
Study 33191260 — intervention group
Group type: COMPARATOR
Intervention: Acetaminophen (APAP) 650 mg
Number of subjects: 0
Study 33191260 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35855580 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief online gatekeeper training
Number of subjects: 0
Study 35855580 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 33568208 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision aid along with decision coaching on PSA screening from a community health worker (CHW)
Number of subjects: 228
Study 33568208 — intervention group
Group type: COMPARATOR
Intervention: Decision aid along with CHW-led interaction on modifying dietary and lifestyle (attention control)
Number of subjects: 228
Study 33568208 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision coaching intervention
Number of subjects: 228
Study 32673262 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth intervention with automated SMS messages for TB contact investigation
Number of subjects: 0
Study 32673262 — intervention group
Group type: COMPARATOR
Intervention: Control group (no automated SMS messages)
Number of subjects: 0
Study 35570153 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-catheter concepts (TCC) by Judkins catheter
Number of subjects: 300
Study 35570153 — intervention group
Group type: COMPARATOR
Intervention: One-catheter concepts (OCC) by Tiger II and BLK catheters
Number of subjects: 300
Study 35570153 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-catheter concepts (TCC)
Number of subjects: 300
Study 35570153 — intervention group
Group type: COMPARATOR
Intervention: One-catheter concepts (OCC)
Number of subjects: 300
Study 32639610 — intervention group
Group type: EXPERIMENTAL
Intervention: Graft tensioning protocol
Number of subjects: 0
Study 35331943 — intervention group
Group type: EXPERIMENTAL
Intervention: smartphone App delivery of caregiver skills with Mentalizing Imagery Therapy (MIT)
Number of subjects: 120
Study 35331943 — intervention group
Group type: COMPARATOR
Intervention: smartphone App delivery of caregiver skills without MIT (control condition)
Number of subjects: 120
Study 35026055 — intervention group
Group type: EXPERIMENTAL
Intervention: Text message intervention (22 fortnightly messages over approximately 10 months)
Number of subjects: 279
Study 34341868 — intervention group
Group type: EXPERIMENTAL
Intervention: HFIT management (herbicides, fertilizers, irrigation, tillage)
Number of subjects: 303
Study 34341868 — intervention group
Group type: COMPARATOR
Intervention: No management (control group)
Number of subjects: 303
Study 32959434 — intervention group
Group type: EXPERIMENTAL
Intervention: Model I: local standard of care with women in general ART services and infants at well-baby clinics
Number of subjects: 0
Study 32959434 — intervention group
Group type: EXPERIMENTAL
Intervention: Model II: integrated maternal and child care approach during the postpartum breastfeeding period
Number of subjects: 0
Study 32959434 — intervention group
Group type: EXPERIMENTAL
Intervention: Model III: referral of women directly to community adherence clubs with infants receiving care at well-baby clinics
Number of subjects: 0
Study 35941566 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine alone
Number of subjects: 40
Study 35941566 — intervention group
Group type: COMPARATOR
Intervention: Gemcitabine plus SBRT
Number of subjects: 40
Study 35941566 — intervention group
Group type: COMPARATOR
Intervention: Both arms
Number of subjects: 40
Study 33811034 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous denosumab 60 mg every 6 months for 24 months
Number of subjects: 98
Study 33811034 — intervention group
Group type: COMPARATOR
Intervention: Placebo every 6 months for 24 months
Number of subjects: 98
Study 32640945 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 1337
Study 32640945 — intervention group
Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 1337
Study 36064438 — intervention group
Group type: EXPERIMENTAL
Intervention: AutoKinetics dosing for other antibiotics (meropenem, vancomycin, ceftriaxone)
Number of subjects: 252
Study 36064438 — intervention group
Group type: COMPARATOR
Intervention: AutoKinetics dosing and Standard dosing (Control)
Number of subjects: 252
Study 36064438 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher dosing (AutoKinetics)
Number of subjects: 252
Study 32901255 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolvaptan 15 mg/day
Number of subjects: 124
Study 32901255 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolvaptan 30 mg/day
Number of subjects: 124
Study 32901255 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 124
Study 32901255 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolvaptan (both dosages)
Number of subjects: 124
Study 35638505 — intervention group
Group type: EXPERIMENTAL
Intervention: High incipient informal social control (ISC)
Number of subjects: 210
Study 35638505 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived informal social control (ISC)
Number of subjects: 210
Study 35638505 — intervention group
Group type: EXPERIMENTAL
Intervention: Bystander legitimacy
Number of subjects: 210
Study 35104279 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 80 mg daily
Number of subjects: 387
Study 35104279 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 387
Study 32841462 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine (LDX)
Number of subjects: 0
Study 32841462 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33332403 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness practice
Number of subjects: 0
Study 33332403 — intervention group
Group type: COMPARATOR
Intervention: Active-control (music listening)
Number of subjects: 0
Study 36404655 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic surgery (ENPG)
Number of subjects: 200
Study 36404655 — intervention group
Group type: COMPARATOR
Intervention: Intensity-modulated radiotherapy (IMRT)
Number of subjects: 200
Study 36035299 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk group based on FRlncRNA signature
Number of subjects: 0
Study 36035299 — intervention group
Group type: COMPARATOR
Intervention: Low-risk group based on FRlncRNA signature
Number of subjects: 0
Study 36035299 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk model
Number of subjects: 0
Study 36035299 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk group
Number of subjects: 0
Study 33025656 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg for 1 year
Number of subjects: 173
Study 33025656 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label high-intensity statin after 1 year
Number of subjects: 173
Study 33025656 — intervention group
Group type: EXPERIMENTAL
Intervention: LDL levels more than 90 mg/dl in the first year
Number of subjects: 173
Study 33025656 — intervention group
Group type: EXPERIMENTAL
Intervention: LDL levels less than 90 mg/dl in the first year
Number of subjects: 173
Study 33025656 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher mean LDL levels during the first postoperative year
Number of subjects: 173
Study 35610702 — intervention group
Group type: EXPERIMENTAL
Intervention: LLLT GaAlAs 940 nm, 5 J/cm2 immediately after surgery and every other day for ten days
Number of subjects: 16
Study 35610702 — intervention group
Group type: COMPARATOR
Intervention: Sham irradiation
Number of subjects: 16
Study 34390392 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol 300 mg
Number of subjects: 54
Study 34390392 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 33048462 — intervention group
Group type: EXPERIMENTAL
Intervention: NobelReplace Tapered implants (Nobel Biocare, Sweden)
Number of subjects: 43
Study 33048462 — intervention group
Group type: COMPARATOR
Intervention: NobelSpeedy implants (Nobel Biocare, Sweden)
Number of subjects: 43
Study 36205580 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate Surgery (IS)
Number of subjects: 4635
Study 36205580 — intervention group
Group type: COMPARATOR
Intervention: Conversion Surgery (CS)
Number of subjects: 4635
Study 36205580 — intervention group
Group type: COMPARATOR
Intervention: Active Surveillance (AS)
Number of subjects: 4635
Study 34107936 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation-based training (Group S)
Number of subjects: 120
Study 34107936 — intervention group
Group type: COMPARATOR
Intervention: Video-based training (Group V)
Number of subjects: 120
Study 32795282 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain Coping Skills Training (CST) program
Number of subjects: 93
Study 32795282 — intervention group
Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 93
Study 36288651 — intervention group
Group type: EXPERIMENTAL
Intervention: Jingyin granules (JY)
Number of subjects: 791
Study 36288651 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 791
Study 33764417 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based exercises
Number of subjects: 0
Study 33764417 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 32769658 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient transcervical Foley catheter
Number of subjects: 126
Study 32769658 — intervention group
Group type: COMPARATOR
Intervention: Inpatient transcervical Foley catheter
Number of subjects: 126
Study 616651636 — intervention group
Group type: EXPERIMENTAL
Intervention: FDA-proposed warnings with pictures illustrating the smoking hazards
Number of subjects: 0
Study 616651636 — intervention group
Group type: COMPARATOR
Intervention: Warnings with the same text information paired with equally aversive but smoking‐irrelevant images
Number of subjects: 0
Study 616651636 — intervention group
Group type: COMPARATOR
Intervention: Text-only warnings
Number of subjects: 0
Study 35857211 — intervention group
Group type: EXPERIMENTAL
Intervention: Yogurt mixed with ioversol
Number of subjects: 136
Study 35857211 — intervention group
Group type: EXPERIMENTAL
Intervention: Lotus root powder mixed with ioversol
Number of subjects: 136
Study 35857211 — intervention group
Group type: EXPERIMENTAL
Intervention: Gas-producing powder
Number of subjects: 136
Study 35857211 — intervention group
Group type: COMPARATOR
Intervention: Control (pure iodine water)
Number of subjects: 136
Study 34246130 — intervention group
Group type: EXPERIMENTAL
Intervention: Methacholine challenge test (MCT) with doses of PC20 ? 8 mg/ml
Number of subjects: 684
Study 34246130 — intervention group
Group type: EXPERIMENTAL
Intervention: Methacholine challenge test (MCT) with doses of PC20 ? 2 mg/ml
Number of subjects: 684
Study 34246130 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of asthmatic wheeze and BHR
Number of subjects: 684
Study 35257222 — intervention group
Group type: EXPERIMENTAL
Intervention: Adhesive, non-impregnated drape applied to the skin prior to incision
Number of subjects: 100
Study 35257222 — intervention group
Group type: COMPARATOR
Intervention: Control group (surgery without a drape)
Number of subjects: 100
Study 32933543 — intervention group
Group type: EXPERIMENTAL
Intervention: GRU-RNN predictive model (Experimental Plans - EPs)
Number of subjects: 100
Study 32933543 — intervention group
Group type: COMPARATOR
Intervention: Clinical Plans (CPs)
Number of subjects: 100
Study 34825503 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight Bias Reduction training enhanced by case-based learning (WBR-I, n=7)
Number of subjects: 42
Study 34825503 — intervention group
Group type: COMPARATOR
Intervention: Standard Weight Bias Reduction training (Control, n=6)
Number of subjects: 42
Study 34825503 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight Bias Reduction training (both groups)
Number of subjects: 42
Study 35420865 — intervention group
Group type: EXPERIMENTAL
Intervention: Prefactual thinking about how a falsehood might become true in the future
Number of subjects: 3607
Study 35420865 — intervention group
Group type: EXPERIMENTAL
Intervention: Prefactual thinking
Number of subjects: 3607
Study 32229029 — intervention group
Group type: EXPERIMENTAL
Intervention: MTA with Er,Cr:YSGG laser
Number of subjects: 90
Study 32229029 — intervention group
Group type: COMPARATOR
Intervention: MTA alone
Number of subjects: 90
Study 36111910 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent aerobic and resistance exercises (three sessions per week for twelve weeks on alternative days)
Number of subjects: 43
Study 36111910 — intervention group
Group type: COMPARATOR
Intervention: Regular lifestyle practices and medical treatment without any exercise intervention
Number of subjects: 43
Study 34453891 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated strand invasion and extensive branch migration
Number of subjects: 0
Study 34453891 — intervention group
Group type: EXPERIMENTAL
Intervention: Crossover-specific double Holliday junction formation
Number of subjects: 0
Study 34453891 — intervention group
Group type: EXPERIMENTAL
Intervention: Noncrossover and crossover recombinants
Number of subjects: 0
Study 33775175 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver-guided pain coping skills training
Number of subjects: 202
Study 33775175 — intervention group
Group type: COMPARATOR
Intervention: Enhanced treatment-as-usual control
Number of subjects: 202
Study 33039447 — intervention group
Group type: EXPERIMENTAL
Intervention: Vericiguat
Number of subjects: 5050
Study 33039447 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5050
Study 33436463 — intervention group
Group type: EXPERIMENTAL
Intervention: Carer Support Needs Assessment Tool for Stroke
Number of subjects: 414
Study 33436463 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 414
Study 34223660 — intervention group
Group type: COMPARATOR
Intervention: CBD 200 mg
Number of subjects: 17
Study 34223660 — intervention group
Group type: COMPARATOR
Intervention: CBD 400 mg
Number of subjects: 17
Study 34223660 — intervention group
Group type: COMPARATOR
Intervention: CBD 800 mg
Number of subjects: 17
Study 34223660 — intervention group
Group type: COMPARATOR
Intervention: CBD (all doses)
Number of subjects: 17
Study 35776835 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapentadol (50 mg extended-release tablets)
Number of subjects: 21
Study 34038229 — intervention group
Group type: EXPERIMENTAL
Intervention: Vignette with potentially traumatic event (PTE)
Number of subjects: 266
Study 34038229 — intervention group
Group type: COMPARATOR
Intervention: Vignette without potentially traumatic event (PTE)
Number of subjects: 266
Study 33278717 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-led intervention (random and assigned peer-leaders)
Number of subjects: 686
Study 33278717 — intervention group
Group type: COMPARATOR
Intervention: Expert-led intervention
Number of subjects: 686
Study 34283710 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin massage
Number of subjects: 73
Study 34283710 — intervention group
Group type: EXPERIMENTAL
Intervention: Music
Number of subjects: 73
Study 34170526 — intervention group
Group type: EXPERIMENTAL
Intervention: Fitspiration images (N = 233)
Number of subjects: 442
Study 34170526 — intervention group
Group type: COMPARATOR
Intervention: Travel images (N = 209)
Number of subjects: 442
Study 36099926 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab (1200 mg, intravenous, once every 3 weeks for 16 cycles or 1 year)
Number of subjects: 778
Study 36099926 — intervention group
Group type: COMPARATOR
Intervention: Placebo (intravenous, once every 3 weeks for 16 cycles or 1 year)
Number of subjects: 778
Study 36099926 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab
Number of subjects: 778
Study 36099926 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 778
Study 34144032 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose Erythropoietin for Asphyxia and Encephalopathy Trial
Number of subjects: 500
Study 34144032 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute abnormalities
Number of subjects: 500
Study 34144032 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic abnormalities
Number of subjects: 500
Study 34144032 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic placental abnormalities
Number of subjects: 500
Study 34144032 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute placental lesions
Number of subjects: 500
Study 32581367 — intervention group
Group type: EXPERIMENTAL
Intervention: CMS4 tumors
Number of subjects: 651
Study 32581367 — intervention group
Group type: EXPERIMENTAL
Intervention: MSI tumors
Number of subjects: 651
Study 32581367 — intervention group
Group type: EXPERIMENTAL
Intervention: Low immunoscore tumors
Number of subjects: 651
Study 33749155 — intervention group
Group type: EXPERIMENTAL
Intervention: Last positive HIV test during breastfeeding
Number of subjects: 822
Study 33749155 — intervention group
Group type: COMPARATOR
Intervention: Last positive HIV test during pregnancy
Number of subjects: 822
Study 33749155 — intervention group
Group type: EXPERIMENTAL
Intervention: Last positive HIV test during breastfeeding with travel time >2 hours to health facility
Number of subjects: 822
Study 33749155 — intervention group
Group type: EXPERIMENTAL
Intervention: Last positive HIV test during breastfeeding with travel time 1-2 hours to health facility
Number of subjects: 822
Study 33749155 — intervention group
Group type: EXPERIMENTAL
Intervention: Last positive HIV test during breastfeeding vs pregnancy
Number of subjects: 822
Study 35581709 — intervention group
Group type: EXPERIMENTAL
Intervention: Video laryngoscope
Number of subjects: 120
Study 35581709 — intervention group
Group type: COMPARATOR
Intervention: USB borescope
Number of subjects: 120
Study 33399006 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary vascular resistance measured by catheterization or approximated from ultrasound data
Number of subjects: 222
Study 33399006 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite clinical score
Number of subjects: 222
Study 33399006 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-minute walk test distance
Number of subjects: 222
Study 33399006 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall mortality
Number of subjects: 222
Study 32893710 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegetarian Diet (VD)
Number of subjects: 31
Study 35728359 — intervention group
Group type: EXPERIMENTAL
Intervention: Fewer thought probes (1-6 probes) during an operation span task
Number of subjects: 0
Study 35728359 — intervention group
Group type: EXPERIMENTAL
Intervention: Fewer thought probes (1-6 probes) during a video lecture
Number of subjects: 0
Study 32921425 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (MEL) therapy as an add-on treatment, 2 to 10 mg, for a long period.
Number of subjects: 11
Study 32921425 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (MEL) therapy, 2 mg slow release, 1 to 2 hours before bedtime, for 3 to 12 weeks.
Number of subjects: 11
Study 32921425 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate release MEL prescribed for REM sleep behavior disorder.
Number of subjects: 11